The Power List 2018 – Champions of Change
Chief Executive Officer and Member of the Board of Directors, TransCelerate Biopharma
Dalvir Gill was appointed CEO of TransCelerate in January 2013 and has since pioneered a number of changes and improvements to the drug development process. As the CEO of TransCelerate and its subsidiary BioCelerate, Dalvir has led a number of initiatives that have helped to make the research and development ecosystem more efficient, safe and innovative. Through TransCelerate, he has made it a priority to not only engage with patients about clinical trials, but to also offer higher value to patients and other healthcare stakeholders through more effective use of trial information.